| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18.09. | Full Transcript: Icecure Medical Q2 2026 Earnings Call | 3 | Benzinga.com | ||
| 11.09. | IceCure Secures China NMPA Approval for ProSense Cryoablation System | 1 | Zacks | ||
| 10.09. | IceCure Medical wins China approval for ProSense cryoablation system | 2 | Seeking Alpha | ||
| 10.09. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 24.08. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 12.08. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 12.08. | IceCure Medical GAAP EPS of -$3.17 misses by $1.65, revenue of $1.82M beats by $0.37M | 3 | Seeking Alpha | ||
| 12.08. | IceCure Medical: IceCure Reports its Financial Results for the First Half of 2026 with 45% Revenue Growth Year-Over-Year | 254 | PR Newswire | The Company is advancing commercial execution and expanding its U.S. commercial footprint through approximately 70% growth in its active installed base following... ► Artikel lesen | |
| ICECURE MEDICAL Aktie jetzt für 0€ handeln | |||||
| 06.08. | IceCure Medical Adds Adventist Health as U.S. Clinical Site for its Post-Marketing "ChoICE" Study for Low-Risk Breast Cancer Cryoablation Treatment | 194 | PR Newswire | Adventist Health Glendale is the first site able to enroll patients in the ChoICE Study after signing both an agreement and receiving IRB approval
The site will... ► Artikel lesen | |
| 26.06. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 26.06. | What's Going On With IceCure Medical Stock On Friday? | 6 | Benzinga.com | ||
| 25.06. | IceCure Medical: IceCure Regains Compliance with Nasdaq Minimum Bid Price Requirement | 184 | PR Newswire | CAESAREA, Israel, June 25, 2026 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive... ► Artikel lesen | |
| 18.06. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 17.06. | IceCure Medical: IceCure Reports 70% Growth in Active U.S. Commercial Install Base for Breast Cancer Cryoablation Following FDA Clearance | 528 | PR Newswire | Increase driven by FDA clearance, clinical guideline support, and increased physician demand. Significant rise in number of leads for ProSense® systems generated... ► Artikel lesen | |
| 02.06. | IceCure Medical to boost share price with 1-for-30 reverse split to regain Nasdaq compliance | 1 | Seeking Alpha | ||
| 02.06. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 02.06. | IceCure Medical Announces 1-for-30 Reverse Share Split to Support Nasdaq Compliance | 460 | PR Newswire | Proactive Step to Regain Nasdaq Compliance as Part of the Company's Broader Capital Markets Strategy
CAESAREA, ISRAEL, June 2, 2026 /PRNewswire/ -- IceCure Medical... ► Artikel lesen | |
| 19.05. | IceCure Medical: IceCure's ProSense Reports Nearly 90% Recurrence-Free Rate for Cryoablation of Kidney Cancer: Data Presented at ECIO 2026 and First-Ever Breast Cryoablation Master Class Overbooked | 298 | PR Newswire | At the annual European Conference on Interventional Oncology, ICESECRET data presented demonstrated 89.4% recurrence-free rate in patients with tumors =3 cm and... ► Artikel lesen | |
| 13.05. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 13.05. | IceCure Medical: IceCure Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement | 368 | PR Newswire | No Immediate Effect on Nasdaq Listing or Trading of the Company's Ordinary Shares
CAESAREA, Israel, May 13, 2026 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM)... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 46,150 | +0,91 % | EQS-News: mAbxience und Sandoz unterzeichnen Kooperationsvereinbarung zur weltweiten Förderung des Zugangs zu Biosimilars | EQS-News: mAbxience
/ Schlagwort(e): Vereinbarung/Sonstiges
mAbxience und Sandoz unterzeichnen Kooperationsvereinbarung zur weltweiten Förderung des Zugangs zu Biosimilars
19.09.2026... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 37,790 | +1,56 % | EQS-News: CPT GmbH: Warren Wise scannt Siemens Healthineers: Scharfe Bilder für Ärzte, unscharfe für Investoren | EQS-News: CPT GmbH
/ Schlagwort(e): Research Update/Jahresbericht
Warren Wise scannt Siemens Healthineers: Scharfe Bilder für Ärzte, unscharfe für Investoren
18.09.2026... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,800 | +1,14 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 8,215 | +4,52 % | Alignment Healthcare Reports Second Quarter 2026 Results, Surpassing High End of Guidance Across All Key Metrics | Generates $1.3 billion in total revenue, representing 31.6% growth year-over-year Grows Medicare Advantage membership 31.5% year-over-year to approximately 294,100 membersRaises the midpoint of all... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 12,410 | +0,24 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 56,61 | +1,49 % | Will M&A Be the Next Growth Factor as BTSG's Cash Flow and Leverage Improve? | ||
| FIREFLY NEUROSCIENCE | 2,020 | 0,00 % | Firefly Neuroscience und NeuroSigma kooperieren bei ADHS-Behandlung | ||
| LIFESTANCE HEALTH GROUP | 11,835 | -2,03 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 17,190 | 0,00 % | Procept BioRobotics verlängert Kreditlaufzeit mit CIBC um ein Jahr | ||
| CARL ZEISS MEDITEC | 31,060 | -1,52 % | Aktien KW 38 Warsh konnte nicht bremsen. Iran verhindert mehr. TACO gefragt! News. Rheinmetall. Mutares. Verbio. Lufthansa. Hapag Lloyd. Carl Zeiss MediTec. Verbio. BASF. DEFAMA. Vonovia. Aroundtown. SFC Energy. Dürr. Evonik. Continental. Elmos Semiconduc | Aktien - es gab eine Leitzinserhöhung in den USA. Da von allen erwartet konnten die Aktienmärkte damit relativ gut umgehen. Selbst Gold und Silber atmeten einmal kurz ein udn setzten danach zum neuen... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 19,725 | +1,73 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen | |
| BILLIONTOONE | 123,25 | +7,72 % | Medicare Lab Fee Changes Impact BillionToOne, CareDx Differently | ||
| GENEDX | 88,40 | 0,00 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| INNOVAGE | 9,000 | 0,00 % | InnovAge Holding Corp. - 8-K, Current Report | ||
| HEARTFLOW | 49,210 | +3,84 % | Canaccord raises HeartFlow stock price target on plaque analysis survey |